Neuromedin U induces an invasive phenotype in CRC cells expressing the NMUR2 receptor

BACKGROUND: Successful colorectal cancer (CRC) therapy often depends on the accurate identification of primary tumours with invasive potential. There is still a lack of identified pathological factors associated with disease recurrence that could help in making treatment decisions. Neuromedin U (NMU...

Descripción completa

Detalles Bibliográficos
Autores principales: Przygodzka, Patrycja, Sochacka, Ewelina, Soboska, Kamila, Pacholczyk, Marcin, Papiewska-Pająk, Izabela, Przygodzki, Tomasz, Płociński, Przemysław, Ballet, Steven, De Prins, An, Boncela, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422652/
https://www.ncbi.nlm.nih.gov/pubmed/34493299
http://dx.doi.org/10.1186/s13046-021-02073-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422652/
https://www.ncbi.nlm.nih.gov/pubmed/34493299
http://dx.doi.org/10.1186/s13046-021-02073-8

Ejemplares similares